Champions Oncology Inc expected to post a loss of 20 cents a share - Earnings Preview

Champions Oncology Inc CSBR is expected to show a fall in quarterly revenue when it reports results on July 16 (estimated) for the period ending April 30 2025

The Hackensack New Jersey-based company is expected to report a 14.2% decrease in revenue to $12.013 million from $14 million a year ago, according to the estimate from one analyst, based on LSEG data.

​LSEG's mean analyst estimate for Champions Oncology Inc is for a loss of 20 cents per share.

The one available analyst rating on the shares is "buy".

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Champions Oncology Inc is $12.00, about 32.5% above its last closing price of $8.10